Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Lexaria Bioscience Corp. (LEXX) had Free Cash Flow of $-4.25M for the most recently reported fiscal quarter, ending 2025-02-28.
| Income Statement Financials | |
$0.17M |
|
$-2.71M |
|
-- |
|
$0.17M |
|
$2.92M |
|
$-2.75M |
|
$0.03M |
|
$-2.72M |
|
$-2.75M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.75M |
|
$-2.75M |
|
$-2.75M |
|
17.51M |
|
17.51M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$7.72M |
|
$0.26M |
|
$0.95M |
|
$8.68M |
|
$1.82M |
|
-- |
|
$0.09M |
|
$1.92M |
|
$6.76M |
|
$6.25M |
|
$6.76M |
|
17.56M |
|
| Cash Flow Statement Financials | |
$-4.22M |
|
$-0.07M |
|
$4.36M |
|
$6.50M |
|
$6.47M |
|
$-0.03M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1581.04% |
|
-1581.04% |
|
-- |
|
-1561.48% |
|
-1559.32% |
|
|
Free Cash Flow |
$-4.25M |
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.53 |
|
171.29 |
|
-40.19% |
|
-43.44% |
|
-31.31% |
|
-40.19% |
|
$0.39 |
|
$-0.24 |
|
$-0.24 |
|